3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
9
Carcinoma, Non-Small-Cell Lung
7
Colorectal Neoplasms
6
Breast Neoplasms
6
Prostatic Neoplasms
5
Papillomavirus Infections
5
Ovarian Neoplasms
4
Neoplastic Cells, Circulating
4
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
3
Lung Neoplasms
3
Melanoma
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Carcinoma, Hepatocellular
2
Thymic aplasia
1
Stomach Neoplasms
1
Solid Tumor, Adult
1
Small Cell Lung Carcinoma
1
Respiratory Distress Syndrome
1
Recurrence
1
Rectal Neoplasms
1
Radiation Injuries
1
Pulmonary Disease, Chronic Obstructive
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Opioid-Related Disorders
1
Interventions
Abiraterone Acetate
6
olaparib
5
Prednisone
5
enzalutamide
3
Prednisolone
3
radium Ra 223 dichloride
2
Pluvicto
2
niraparib
1
fludarabine
1
darolutamide
1
afuresertib
1
abiraterone
1
Docetaxel
1
Cyclophosphamide
1
Clinical Trials, Phase I as Topic
1
Blood Specimen Collection
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Metastatic Castration-resistant Prostate Cancer
×
Blood Specimen Collection
×
Clear all
NCT06492122
2026-05-26
ProTACT
Full-Life Technologies GmbH
Phase 1
Recruiting
50 enrolled